IG Confirms Many Recovery Act Criminal Investigations
Client Alert | less than 1 min read | 11.03.11
In what should serve as a warning that use of Recovery Act funds continues to draw close scrutiny from federal watchdogs, in written testimony on November 2 before a House subcommittee, DoE Inspector General Friedman revealed that his office has initiated over 100 criminal investigations involving “various schemes, including the submission of false information [and] claims for unallowable or unauthorized expenses,” under the Recovery Act. He also confirmed that his office has “ongoing and planned reviews” of Recovery Act funding and usage.
Contacts
Insights
Client Alert | 3 min read | 01.21.26
Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up of Criminal Corporate Healthcare Enforcement
On January 13, 2026, Miami-based pharmaceutical wholesaler Atlantic Biologicals Corporation entered into a two-year DPA, admitting to conspiracy to distribute and dispense controlled substances, including more than 14 million opioid doses to “pill mill” pharmacies in Texas at a markup. The DOJ and DEA underscored the company’s deliberate evasion of compliance checks and disregard for red flags signaling diversion.
Client Alert | 3 min read | 01.21.26
FedRAMP Proposes Updates to Authorization Process—Six New RFCs Released for Public Comment
Client Alert | 3 min read | 01.20.26
DoW Joins SBA’s Fight Against Alleged Pass-Through Fraud in the 8(a) Program
Client Alert | 3 min read | 01.20.26
Federal Government Challenges Minnesota Law Requiring Affirmative Action in State Government
